The stocks of the companies announcing Q3 results will be kept under active watch. Notably, markets have been seeing a ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

In an exchange filing last month, the company had informed that a meeting of its Board of Directors is scheduled for this ...

Alembic Pharmaceuticals reported a 23.29% decline in Q3 FY25 net profit at ₹138.42 crore, despite a 3.81% revenue increase to ...

Divi's Labs also said in its exchange filing that it has commenced commercial operations from a part of the Phase 1 of the ...

On Saturday, after market hours, Aarti Industries posted a 63 per cent decline in its consolidated net profit of Rs 46 crore ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

Booz Allen Hamilton (BAH) reported Q3 EPS of $1.55, beating estimates of $1.51. Sales of $2.92B and backlog growth of 14.8% ...